|
PRIM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5970999999948E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.046970E-04 |
| Normal-vs-Stage2 |
1.86639999999461E-06 |
| Normal-vs-Stage3 |
7.427600E-04 |
| Normal-vs-Stage4 |
7.51110000000166E-05 |
| Stage1-vs-Stage2 |
3.687900E-02 |
| Stage1-vs-Stage3 |
9.915200E-01 |
| Stage1-vs-Stage4 |
2.460000E-01 |
| Stage2-vs-Stage3 |
6.182200E-02 |
| Stage2-vs-Stage4 |
4.015200E-01 |
| Stage3-vs-Stage4 |
3.026400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.59030000000438E-05 |
| Normal-vs-AfricanAmerican |
1.736420E-01 |
| Normal-vs-Asian |
5.000800E-04 |
| Caucasian-vs-AfricanAmerican |
2.440200E-01 |
| Caucasian-vs-Asian |
5.942000E-01 |
| AfricanAmerican-vs-Asian |
1.688250E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.45479999999776E-05 |
| Normal-vs-Female |
2.41489999999178E-05 |
| Male-vs-Female |
4.736800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.135700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.75993000000041E-05 |
| Normal-vs-Age(61-80Yrs) |
7.29070000038412E-07 |
| Normal-vs-Age(81-100Yrs) |
1.440780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.776360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.910040E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.500600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.708800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.025600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.832000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.460000E-01 |
| Classical-VS-Follicular |
1.24800170198114E-12 |
| Classical-VS-Other |
4.480600E-01 |
| Classical-VS-Normal |
2.620900E-03 |
| Tall-VS-Follicular |
1.7018099999988E-05 |
| Tall-VS-Other |
4.024000E-01 |
| Tall-VS-Normal |
9.590300E-02 |
| Follicular-VS-Other |
1.195590E-01 |
| Follicular-VS-Normal |
8.71058780660405E-12 |
| Other-VS-Normal |
8.812200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.18850000238891E-08 |
| Normal-vs-N1 |
3.259100E-03 |
| N0-vs-N1 |
2.345400E-01 |
|
|
